CVS Health Free cash flow increased by 2559.2% to $2.61B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 138.6%, from $1.09B to $2.61B. Over 2 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -29.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests strong operational efficiency and the ability to self-fund future innovation or return capital to shareholders, while a decrease may indicate heavy capital expenditure cycles or declining operational profitability.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
High-growth semiconductor and AI infrastructure peers typically prioritize reinvestment, so free cash flow margins are often compared against R&D intensity and capital expenditure requirements of industry rivals.
cf_free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.36B | $4.91B | $3.41B | $2.51B | $5.04B | $8.54B | $6.45B | $5.32B | $2.17B | $4.20B | $2.45B | -$1.42B | $1.09B | $3.81B | $1.29B | $98.00M | $2.61B |
| QoQ Change | — | -8.4% | -30.6% | -26.3% | +100.4% | +69.7% | -24.5% | -17.6% | -59.2% | +93.4% | -41.6% | -157.7% | +177.2% | +249.2% | -66.2% | -92.4% | >999% |
| YoY Change | — | — | — | — | -6.1% | +73.9% | +156.9% | +5.6% | -74.6% | -35.0% | -53.9% | -165.2% | — | -9.2% | -47.4% | +106.9% | +138.6% |